Correction to: Certolizumab Pegol in the Treatment of Psoriasis and Psoriatic Arthritis: Preliminary Real-Life Data

被引：0
|
作者：
Annunziata Dattola
Maria Vittoria Cannizzaro
Mauro Mazzeo
Luca Bianchi
机构：
[1] University of Rome “Tor Vergata”,Department of Dermatology
来源：
Dermatology and Therapy | 2018年 / 8卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In the original publication, part Fig. 3b and c were interchanged. The correct versions are given below.
引用
下载
收藏
页码：171 / 171
相关论文
共 50 条
  • [41] Health-related quality of life in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis treated with certolizumab pegol
    Sarobe, Maite
    Arrondo, Amaya
    Ibarrondo, Oliver
    Mar, Javier
    FARMACIA HOSPITALARIA, 2022, 46 (01) : 27 - 30
  • [42] Effectiveness and Retention Rate of Certolizumab Pegol in Spondyloarthritis. Real Life Data
    Exposito, Rosa
    Gonzalez, Carlos M.
    Garcia-Portales, Rosa
    Urruticoechea-Arana, Ana
    Ramon Lamua, Jose
    del Pilar Navarro, Maria
    Rey Rey, Jose Santos
    Fernandez, Manuel
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [43] The Potential Benefits of Certolizumab Pegol in Patients with Concurrent Psoriatic Arthritis and Chronic Plaque Psoriasis: A Case Series and Review of the Literature
    David Rutkowski
    Hector Chinoy
    Richard B. Warren
    Dermatology and Therapy, 2019, 9 : 373 - 381
  • [44] The Potential Benefits of Certolizumab Pegol in Patients with Concurrent Psoriatic Arthritis and Chronic Plaque Psoriasis: A Case Series and Review of the Literature
    Rutkowski, David
    Chinoy, Hector
    Warren, Richard B.
    DERMATOLOGY AND THERAPY, 2019, 9 (02) : 373 - 381
  • [45] Real life experience of apremilast in psoriasis and arthritis psoriatic patients: Preliminary results on metabolic biomarkers
    Mazzilli, Sara
    Lanna, Caterina
    Chiaramonte, Carlo
    Cesaroni, Gaia Maria
    Zangrilli, Arianna
    Palumbo, Vincenzo
    Cosio, Terenzio
    Dattola, Annunziata
    Gaziano, Roberta
    Galluzzo, Marco
    Chimenti, Maria Sole
    Gisondi, Paolo
    Bianchi, Luca
    Campione, Elena
    JOURNAL OF DERMATOLOGY, 2020, 47 (06): : 578 - 582
  • [46] Efficacy of adalimumab in psoriatic arthritis (PsA) in real-life clinical practice: Preliminary results of STEREO
    Van den Bosch, Filip
    Manger, Bernhard
    Frank, Martina
    Kupper, Hartmut
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) : AB184 - AB184
  • [47] Secukinumab Drug Survival in Psoriasis and Psoriatic Arthritis Patients: A 24-Month Real-Life Study
    Ortolan, Augusta
    Lorenzin, Mariagrazia
    Leo, Giovanni
    Pampaloni, Francesca
    Messina, Francesco
    Doria, Andrea
    Piaserico, Stefano
    Ramonda, Roberta
    DERMATOLOGY, 2022, 238 (05) : 897 - 903
  • [48] Certolizumab Pegol: A Review of Its Use in Patients with Axial Spondyloarthritis or Psoriatic Arthritis
    Sohita Dhillon
    Drugs, 2014, 74 : 999 - 1016
  • [49] IMPROVEMENTS IN EXTRA-ARTICULAR MANIFESTATIONS OF PSORIATIC ARTHRITIS OVER 96 WEEKS OF CERTOLIZUMAB PEGOL TREATMENT
    FitzGerald, O.
    Fleischmann, R.
    Hoepken, B.
    Peterson, L.
    Gladman, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 349 - 349
  • [50] EFFECTIVENESS OF CERTOLIZUMAB PEGOL IN PSORIATIC ARTHRITIS. RELATIONSHIP WITH SMOKING STATUS AND BMI
    Campos Esteban, J.
    Conesa Mateos, A.
    Fernandez-Prada, M.
    Exposito-Molinero, R.
    Rubio Munoz, P.
    Lamua-Riazuelo, J. R.
    Navarro-Alonso, P.
    Ahijado Guzman, P.
    Garcia-Portales, R.
    Urruticoechea-Arana, A.
    Gonzalez Fernandez, C. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1588 - 1588
12345